VantAI
Bruno Correia serves as an Associate Professor at École polytechnique fédérale de Lausanne since March 2015, following a role as Assistant Professor. Prior to this, Bruno Correia was a Postdoctoral Fellow at The Scripps Research Institute from September 2011 to February 2015 and completed a PhD at the University of Washington from 2006 to 2011. Bruno Correia's academic journey began at Instituto Gulbenkian de Ciencia as a student from 2004 to 2005. Education was further solidified with a degree from the University of Washington in 2009.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
VantAI
1 followers
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods.